Found: 58 articles

Article Edition
M.Ye. Statsenko, S.V. Turkina, N.N. Shilina, M.A. Kosivtsova
Potentials for the additional medical correction using cytoprotectors in patients with chronic heart failure and nonalcoholic fatty liver disease
№1 / 2017
N.T. Vatutin, A.S. Smirnova, Ye.S. Gasendich
The evaluation of lipid profile in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease
№6 / 2016
V.V. Cheltsov
Torasemide and furosemide: similarities and differences
№5 / 2016
S.N. Tolpygina
Place of eplerenone in the therapy of cardiovascular diseases
№5 / 2016
M.Ye. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya
Application of Mildronate in patients with comorbidity: focus on cardioneurology
№5 / 2016
V.V. Cheltsov, Yu.Sh. Gushina, T.S. Illarioniva, E.А. Korovyakova, A.E. Moiseeva, A.P. Pereversev, Ye.Yu. Stefanenko, S.K. Ziryanov
Angiotensin II receptor blockers: focus on cardesartan
№4 / 2016
V.V. Cheltsov, A.I. Martynov, Yu.Sh. Gushchina, T.S. Illarionova, E.A. Korovyakova
Metabolic therapy in chronic heart failure
№4 / 2016
V.V. Cheltsov, A.I. Martynov
Effectiveness of blockers of the mineralocorticoid receptors (spironolactone, eplerenone) in chronic heart failure
№1 / 2016
M.Ye. Statsenko, S.V. Turkina
The ability of torasemide from the standpoint of evidence-based medicine
№1 / 2016
M.E. Statsenko, S.V. Turkina
Algorithm of differential prescription of cytoprotectors in patients with chronic heart failure and disorders of carbohydrate metabolism
№3 / 2015


Бионика Медиа